Peer-reviewed veterinary case report
Atenolol rescues premature mortality in genetic mouse models of sudden unexpected death in epilepsy.
- Journal:
- Epilepsia
- Year:
- 2026
- Authors:
- Soh, Ming S et al.
- Affiliation:
- The Florey Institute of Neuroscience and Mental Health · Australia
- Species:
- rodent
Abstract
OBJECTIVE: Sudden unexpected death in epilepsy (SUDEP) is the leading cause of premature mortality in epilepsy. Genetic studies have identified that loss-of-function (LOF) KCNH2 variants are enriched in SUDEP patients, suggesting that they may act as a risk factor. KCNH2 encodes the K11.1 channel, with LOF pathogenic variants a cause of long-QT syndrome (LQTS), increasing the risk of arrhythmia and sudden cardiac death. Here, we engineered preclinical rodent models that combine epilepsy-causing pathogenic variants with heterozygous Kcnh2 knockout mice to explore the impact of reduced K11.1 channel function on mortality. METHODS: Both the Gabrg2and Hcn1genetic mouse models of monogenic epilepsy were crossed with Kcnh2mice. All genotypes were video-recorded post-weaning and time to death was measured. Additional mice underwent surgery to enable simultaneous electrocorticography and electrocardiography recordings. Atenolol was delivered in drinking water to a subset of mice. RESULTS: Both single mutant Gabrg2and Hcn1mice displayed spontaneous seizures recapitulating the human phenotypes. Single mutant Kcnh2mice exhibited an LQTS phenotype. Double mutant mice (Gabrg2/Kcnh2and Hcn1/Kcnh2) had both seizure and prolonged QT interval phenotypes that were similar to their respective single mutant mice. Survival analysis revealed that Gabrg2/Kcnh2and Hcn1/Kcnh2mice experienced a disproportionately higher rate of seizure-related death when compared to wild-type and their respective single mutant littermates. Oral administration of the cardiac-selective β-blocker atenolol significantly improved survival in Gabrg2/Kcnh2, Hcn1, and Hcn1/Kcnh2mice. Atenolol attenuated the sympathetic cardiac response to non-terminal seizures. SIGNIFICANCE: The data support the premise that LOF KCNH2 variants can contribute to SUDEP risk in a subset of epilepsy patients. Our findings also highlight the potential use of β-blockers as a prevention strategy in SUDEP.
Find similar cases for your pet
PetCaseFinder finds other peer-reviewed reports of pets with the same symptoms, plus a plain-English summary of what was tried across them.
Search related cases →Original publication: https://pubmed.ncbi.nlm.nih.gov/40991209/